PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18763755-1	2008	We previously reported that 1 (BMS-536924), a benzimidazole inhibitor of the insulin-like growth factor-1 receptor, had demonstrated in vivo antitumor activity.	benzimidazole	46-59	insulin like growth factor 1 receptor	Homo sapiens	77-114	
20545947-1	2010	From an azaindole lead, identified in high throughput screen, a series of potent bis-azaindole inhibitors of IGF1-R have been synthesized using rational drug design and SAR based on a in silico binding mode hypothesis.	benzimidazole	8-17	insulin like growth factor 1 receptor	Homo sapiens	109-115	
21220496-10	2011	These data suggest that benzimidazole IGF-1R/InsR inhibitors may select for upregulation and be effluxed by the ATP-binding cassette transporter, BCRP, contributing to resistance.	benzimidazole	24-37	insulin like growth factor 1 receptor	Homo sapiens	38-44	
20153189-0	2010	SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors.	benzimidazole	30-43	insulin like growth factor 1 receptor	Homo sapiens	50-56	
18572407-0	2008	Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors.	benzimidazole	50-63	insulin like growth factor 1 receptor	Homo sapiens	70-76